SEARCH RESULTS FOR: ("Shape moulding machines for EPP Login [www.yyeps.com]EPS Machines")(9598 results)
100% Medical Grade Manuka honey. Activon Tube contains 100% Medical Grade Manuka honey with no additives. This wound filler will eliminate odors and provides a moist wound healing environment that facilitates autolytic debridement. Activon Tube can be used as a wound filler for use in cavities.
BRIGHTWAKE LIMITED
CR4493
In Commercial Distribution
- 05060031482010 ()
- 05060031482003 ()
- 05060031482027 ()
- Weight: 20 Gram
- Medical honey liquid barrier dressing
100% Medical Grade Manuka honey. Activon Tube contains 100% Medical Grade Manuka honey with no additives. This wound filler will eliminate odors and provides a moist wound healing environment that facilitates autolytic debridement. Activon Tube can be used as a wound filler for use in cavities.
BRIGHTWAKE LIMITED
CR3830
In Commercial Distribution
- 05060031471199 ()
- 05060031471182 ()
- 05060031471205 ()
- Weight: 25 Gram
- Medical honey liquid barrier dressing
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0066
In Commercial Distribution
- 07540127000505 ()
- 07540127000499 ()
- 07540127000512 ()
- Area/Surface Area: 512 Square inch
CL1632
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0065
In Commercial Distribution
- 07540127000444 ()
- 07540127000437 ()
- 07540127000451 ()
- Area/Surface Area: 256 Square inch
CL1616
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0064
In Commercial Distribution
- 07540127000413 ()
- 07540127000406 ()
- 07540127000420 ()
- Area/Surface Area: 128 Square inch
CL0816
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0063
In Commercial Distribution
- 07540127000383 ()
- 07540127000376 ()
- 07540127000390 ()
- Area/Surface Area: 36 Square inch
CL0606
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0062
In Commercial Distribution
- 07540127000352 ()
- 07540127000345 ()
- 07540127000369 ()
- Area/Surface Area: 20 Square inch
CL0405
- Wound-nonadherent dressing, absorbent, antimicrobial
The seca 115 PC software is for administering weight, height, bioimpedance and vital measurements and for calculating automatically parameters such as FMI (fat mass index) which can be derived from these measurements. Results are displayed in graphical form and provide support with the following medical issues:
• Documentation of weight changes
• Documentation of energy expenditure and energy reserves
• Documentation of cardiometabolic risk
• Documentation of metabolic activity and the success of a training program, e.g. within the framework of rehabilitation or physiotherapy
• Documentation of a patient’s fluids status and documentation of changes in fluids
• Documentation of changes in vital signs
seca GmbH & Co. KG
115
Not in Commercial Distribution
- 04012030013406 ()
1151300010
- Medical equipment clinical data interfacing software
The seca 115 PC software is for administering weight, height, bioimpedance and vital measurements and for calculating automatically parameters such as FMI (fat mass index) which can be derived from these measurements. Results are displayed in graphical form and provide support with the following medical issues:
• Documentation of weight changes
• Documentation of energy expenditure and energy reserves
• Documentation of cardiometabolic risk
• Documentation of metabolic activity and the success of a training program, e.g. within the framework of rehabilitation or physiotherapy
• Documentation of a patient’s fluids status and documentation of changes in fluids
• Documentation of changes in vital signs
seca GmbH & Co. KG
115
Not in Commercial Distribution
- 04012030013383 ()
1151306010
- Medical equipment clinical data interfacing software
The seca 115 PC software is for administering weight, height, bioimpedance and vital measurements and for calculating automatically parameters such as FMI (fat mass index) which can be derived from these measurements. Results are displayed in graphical form and provide support with the following medical issues:
• Documentation of weight changes
• Documentation of energy expenditure and energy reserves
• Documentation of cardiometabolic risk
• Documentation of metabolic activity and the success of a training program, e.g. within the framework of rehabilitation or physiotherapy
• Documentation of a patient’s fluids status and documentation of changes in fluids
• Documentation of changes in vital signs
seca GmbH & Co. KG
115
Not in Commercial Distribution
- 04012030013376 ()
1151303010
- Medical equipment clinical data interfacing software